COMP <GO>
PRLD vs IRD // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Prelude Therapeutics Incorporated (NASDAQ) VS. Opus Genetics Inc. (NASDAQ) • 15-METRIC TALLY: PRLD 3
— IRD 2
■ METRIC PARITY
LAST: $3.84 (-1.03%) • MKT CAP: $309.6M
options-implied-move
—
LAST: $3.70 (+0.82%) • MKT CAP: $305.3M
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PRLD VS. IRD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PRLD | IRD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -17.23% | -11.61% | -5.62 | IRD | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 73.40% | 29.10% | +44.30 | PRLD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 5/9 | -1.00 | IRD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.9 | 40.0 | +8.90 | PRLD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $309.6M | $305.3M | $4.3M | PRLD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PRLD REV | IRD REV | PRLD GROSS % | IRD GROSS % | PRLD FCF | IRD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $12.1M | $14.2M | — | — | -$56.4M | -$35.3M |
| FY 2024 | $7.0M | $11.0M | — | — | -$103.7M | -$25.6M |
| FY 2023 | $370.4M | $19.0M | — | — | -$107.1M | -$1.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PRLD // BETA —
IRD // BETA —